[ON THE EFFECT OF MONOAMINE OXIDASE INHIBITORS (MAOI) ON THE EFFECT OF ORALLY ADMINISTERED M-HYDROXY-1-PHENYL-2-AMINOETHANOL HCL (NOVADRAL) ON THE BLOOD CIRCULATION].
D001794:Blood Pressure; D019856:Ethanolamine; D006339:Heart Rate; D007490:Iproniazid; D007520:Isocarboxazid; D008996:Monoamine Oxidase Inhibitors; D009526:Nialamide; D009655:Octopamine / Q000031:analogs & derivatives; D010600:Pharmacology; D010656:Phenylephrine; D011674:Pulse
D008996:Monoamine Oxidase Inhibitors; D009655:Octopamine; D010656:Phenylephrine; D007520:Isocarboxazid; D019856:Ethanolamine; C005310:norfenefrine; D007490:Iproniazid; D009526:Nialamide
BLOOD PRESSURE; IPRONIAZID; ISOCARBOXAZID; MONOAMINE OXIDASE INHIBITORS; NIALAMIDE; PHARMACOLOGY; PHENYLEPHRINE; PULSE
UBER DEN EINFLUSS VON MONOAMINOOXYDASE-HEMMERN (MAOH) AUF DIE KREISLAUFWIRKSAMKEIT VON ORAL EINGENOMMENEM M-HYDROXY-PHENYL(1)-AETHANOL(1)-AMIN(2)-HYDROCHLORID (NOVADRAL)